Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Breast Cancer Reports

Issue 1/2019

Content (4 Articles)

Ultrasound Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Diagnosing and Managing the Malignant Axilla in Breast Cancer

Karina Cox, Meng-Xing Tang, Jiaqi Zhu

Open Access Breast Cancer Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Is Ultrafast or Abbreviated Breast MRI Ready for Prime Time?

Ritse M. Mann, Jan C. M. van Zelst, Suzan Vreemann, Roel D. M. Mus

Open Access Breast Cancer Breast Cancer Imaging and Screening (N Sharma, Section Editor)

The Role of Deep Learning in Breast Screening

Hugh Harvey, Edith Karpati, Galvin Khara, Dimitrios Korkinof, Annie Ng, Christopher Austin, Tobias Rijken, Peter Kecskemethy

Open Access Magnetic Resonance Imaging Breast Cancer Imaging and Screening (N Sharma, Section Editor)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment

Georg J. Wengert, Thomas H. Helbich, Doris Leithner, Elizabeth A. Morris, Pascal A. T. Baltzer, Katja Pinker

Dec 18
Issue: 4/2018
Jun 19
Issue: 2/2019

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits